cover
Article Per Year (5 Year)
All
Home Page
OAI Link
Editorial Team
Contact
Reviewer
Google Scholar
Contact Name
Teuku Rizky Noviandy
Contact Email
trizkynoviandy@gmail.com
Phone
+626282275731976
Journal Mail Official
editorial-office@heca-analitika.com
Editorial Address
Jl. Makam T. Nyak Arief Kompleks BUPERTA Blok L7B, Lamgapang, Aceh Besar, Provinsi Aceh
Location
Kab. aceh besar,
Aceh
INDONESIA
Malacca Pharmaceutics
Published by PT. Heca Sentra Analitika
ISSN : -     EISSN : 29881064     DOI : https://doi.org/10.60084/mp
Core Subject : Health, Science, Agriculture,
Agriculture, Biological Sciences & Forestry Biochemistry, Genetics & Molecular Biology Chemistry Immunology & microbiology Medicine & Pharmacology
Malacca Pharmaceutics is a premier interdisciplinary platform dedicated to fostering the exchange of cutting edge research and ideas in the rapidly evolving fields of pharmaceutical science and technology. Our mission is to provide a comprehensive and authoritative forum for scientists, researchers, and practitioners from diverse disciplines to share and advance their knowledge in the development, optimization, and application of innovative therapeutic strategies. The scope of the Malacca Pharmaceutics Journal encompasses a wide range of topics, including, but not limited to:Pharmaceutical formulation, delivery and controlled-release systems for drugs, vaccines, and biopharmaceuticals, pharmaceutical process, engineering, biotechnology, and nanotechnology, devices, cells, molecular biology, and materials science related to drugs and drug delivery pharmacogenetics and pharmacogenomics, biopharmaceutics,nanomedicine, drug targeting, drug design, pharmacokinetics, toxicokinetics, pharmacodynamics, drug discovery, drug design, medicinal chemistry, combinatorial chemistry, SAR, structure-property correlations, molecular modeling, pharmacophore, and bioinformatics
Arjuna Subject : Pharmacology, Toxicology and Pharmaceutics - Ilmu Farmasi
Articles 5 Documents
 1 
Search results for , issue "Vol. 1 No. 1 (2023): June 2023" : 5 Documents clear
Ficus minahassae (Teijsm. & de Vriese) Miq.: A Fig Full of Health Benefits from North Sulawesi, Indonesia: A Mini Review Abas, Abdul Hawil; Tallei, Trina Ekawati; Idroes, Rinaldi; Fatimawali, Fatimawali
Malacca Pharmaceutics Vol. 1 No. 1 (2023): June 2023
Publisher : Heca Sentra Analitika

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.60084/mp.v1i1.24

Abstract

Plants have been widely utilized as traditional medicine for an extended period of time. Numerous traditional remedies have demonstrated inherent anti-disease properties. Among the countries that extensively rely on traditional medicine, Indonesia stands out. Within the region of North Sulawesi, Indonesia, Ficus minahassae, an indigenous plant possessing several health benefits, is utilized by the local community as a traditional medicinal resource. This plant is employed for the treatment of various ailments such as rheumatism, physical discomfort, stimulation of lactation in breastfeeding women, bruises, relapse, fever, fatigue, migraines, bodily pain, headaches, convulsions, colds, coughs, influenza, and fractures. Typically, the leaves, roots, and stems of F. minahassae are boiled and consumed. Additionally, this plant has been reported to possess antibacterial and antioxidant properties. However, scientific investigations exploring the health advantages of F. minahassae are significantly limited in comparison to other traditional medicines. Consequently, it is highly recommended to conduct further research on the health benefits associated with this plant.
Antibacterial Activity of n-Hexane Dragon’s Blood Resin Extract (Daemonorops draco wild Blume) from Bener Meriah, Aceh Province, Indonesia Khairan, Khairan; Arini, Musfira; Idroes, Rinaldi; Awang, Khalijah; Jacob, Claus
Malacca Pharmaceutics Vol. 1 No. 1 (2023): June 2023
Publisher : Heca Sentra Analitika

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.60084/mp.v1i1.29

Abstract

The dragon’s blood resin (Daemonorops draco wild Blume) has been used in folk medicine for pharmacological activities such as antimicrobial, antivirus, anti-inflammation, gastrointestinal disorders, blood circulation dysfunctions, antitumor, and cancer. This study was designated to evaluate the antibacterial activity of n-Hexane dragon’s blood resin extract against Staphylococcus aureus ATCC 25923, Escherichia coli ATCC 25922, and Candida albicans 10231. The other purpose of this study was to determine the secondary metabolites compound of n-Hexane dragon’s blood resin extract. The antimicrobial activities of the n-Hexane dragon’s blood resin extract was determined using well diffusion method and the results showed that the extract at concentration of 15% exhibited antimicrobial activities against Staphylococcus aureus ATCC 25923, Escherichia coli ATCC 25922, and Candida albicans 10231 with the diameter inhibition of 13.20 mm; 21.3 mm; and 13.0 mm respectively. The phytochemicals screening showed that the extract contains secondary metabolites in the form of flavonoids. The GC-MS analysis showed that n-Hexane dragon’s blood resin extract contains 48 chemicals compounds, and the compound at RT 26 was indicated a Drachorhodin compound (C17H 18O3) with the mass ration of m/z was 270 g/mol. Overall, the n-Hexane dragon’s blood resin extract be a good choice for antimicrobial agent against bacteria and fungi.
A Review of the Ethno-dentistry Activities of Calotropis gigantea Ningsih, Diana Setya; Celik, Ismail; Abas, Abdul Hawil; Bachtiar, Boy Muhclis; Kemala, Pati; Idroes, Ghazi Mauer; Maulydia, Nur Balqis
Malacca Pharmaceutics Vol. 1 No. 1 (2023): June 2023
Publisher : Heca Sentra Analitika

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.60084/mp.v1i1.31

Abstract

Calotropis gigantea is a medicinal herb that thrives in arid climates. All parts of this plant are rich in secondary metabolites, which are very beneficial for health. Phytochemicals of this plant include flavonoid, alkaloids, steroids, cardiac glycosides, and terpenoids, which have a wide range of pharmacological effects. The potential of metabolit compound from C. gigantea can be used in dental treatment. This review describes the potential use of C. gigantea in ethno-dentistry, specifically as anti-caries, soft tissue inflammation (periodontitis and gingivitis), degenerative diseases (tumor/cancer), and wound healing. This review provides general perspectives and basic literature on the use of C. gigantea in the field of etno-dentistry.
Prediction of Pharmacokinetic Parameters from Ethanolic Extract Mane Leaves (Vitex pinnata L.) in Geothermal Manifestation of Seulawah Agam Ie-Seu’um, Aceh Maulydia, Nur Balqis; Khairan, Khairan; Noviandy, Teuku Rizky
Malacca Pharmaceutics Vol. 1 No. 1 (2023): June 2023
Publisher : Heca Sentra Analitika

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.60084/mp.v1i1.33

Abstract

The Mane plant (Vitex pinnata L.) is traditionally used as medicine in Aceh Province, Indonesia. This study aimed to predict the pharmacokinetic parameters of compounds in the ethanolic extract of Mane leaf (EEML), including the absorption, distribution, metabolism, excretion, and toxicity (ADMET), by in-silico approach. The method used was to analyze the compounds using a web-predictor server and molecular docking. Gas chromatography-mass spectrometry (GCMS) analysis of EEML showed the presence of active compounds, including phytol (60.93%), acorenol (8.56%), n-hexadecanoic acid (4.89%), trans-Z-alpha-bisabolene epoxide (2.7%) and cedrane (2.03%). Lipinski's rule of five states that all compounds had a deviation of less than 2. Pharmacokinetic parameters suggested that phytol was moderately absorbed in the gastrointestinal tract and had a toxicity level of 5 with lethal doses (LD50) >5000 mg/kg. Molecular docking results showed that phytol could be used against the targeted enzyme Staphylococcus aureus. In conclusion, our study suggests that the active compounds of EEML may have potential as a drug candidate.
Formulation and Antibacterial Activity of Averrhoa bilimbi L. Fruits Extract in Vegetable Oil-Based Liquid Hand Soap Hayati, Rima; Sari, Amelia; Hanum, Faridah; Nabilah, Nada; Earlia, Nanda; Lukitaningsih, Endang
Malacca Pharmaceutics Vol. 1 No. 1 (2023): June 2023
Publisher : Heca Sentra Analitika

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.60084/mp.v1i1.35

Abstract

The main method of preventing infections is good hand cleanliness. Bilimbi (Averrhoa bilimbi) fruits contains flavonoids, which have been tested for antibacterial activity. Polar chemicals like flavonoids are often extracted using ethanol as a solvent.  Therefore, this study aimed to formulate an ethanol extract of A. bilimbi fruits in the form of hand soap. This formulation used vegetable oils such as olive oil, coconut oil, and castor oil, which are high in fatty acids to maintain healthy skin. Antibacterial activity was carried out against Staphylococcus aureus and Escherichia coli. The extract was prepared by maceration for 5 days using an ethanol solvent. Liquid soap contained A. bilimbi fruit extracts at 5% (F1) and 10% (F2). The F1 and F2 organoleptic tests showed the preparation as a thick liquid with a distinctive coconut oil aroma, light brown (F1) and brown (F2) color. pH values of 5.8 (F1) and 5.6 (F2). Foam height stability was 71.5% (F1) and 73.1% (F2). The specific gravity for the two formulas was 1.02 g/mL. The viscosity of F1 and F2 was 137.6 cP and 163.5 cP, respectively. Inhibition power against S. aureus using the agar diffusion method by measuring the diameter of the inhibition zone showed strong (F1) and very strong (F2) categories The inhibition against S. aureus showed strong (F1) and very strong (F2) categories. While F1 has no inhibitory power against E. coli, F2 showed inhibition in the strong category. Based on our research, it can be concluded that A. bilimbi fruit extract can produce good hand soap and have bacteria-inhibiting activity. However, further formula development is still needed to obtain preparations that meet all the requirements and stability tests.

Page 1 of 1 | Total Record : 5

 1 

Filter by Year

2023 2023


Reset
Filter By Issues
All Issue Vol. 4 No. 1 (2026): March 2026 (In Press) Vol. 3 No. 2 (2025): September 2025 Vol. 3 No. 1 (2025): March 2025 Vol. 2 No. 2 (2024): September 2024 Vol. 2 No. 1 (2024): March 2024 Vol. 1 No. 2 (2023): October 2023 Vol. 1 No. 1 (2023): June 2023